Cyclin-dependent kinase 4 signaling acts as a molecular switch between syngenic differentiation and neural

Janet Lee1, Jeong-Hwa Baek, Kyu-Sil Choi

  • 1Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi, Korea.

Insights

Cyclin-dependent kinase (CDK) inhibitors, specifically CDK4 inhibitors, promote neural cell transdifferentiation in human mesenchymal stem/stromal cells (MSCs). CDK4 signaling acts as a switch, controlling neural versus syngenic differentiation in MSCs.

Area of Science:

  • Stem cell biology
  • Molecular mechanisms of cell differentiation
  • Neuroscience

Background:

  • Multipotent mesenchymal stem/stromal cells (MSCs) possess differentiation potential into various cell types.
  • The precise molecular pathways governing MSC transdifferentiation remain incompletely understood.
  • Understanding these mechanisms is crucial for regenerative medicine and cell-based therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms controlling MSC transdifferentiation.
  • To investigate the role of cyclin-dependent kinase (CDK) signaling in MSC differentiation.
  • To explore the potential of CDK inhibitors in directing MSC fate towards neural lineages.

Main Methods:

  • Treatment of human adipose- and bone marrow-derived MSCs with CDK inhibitors, particularly CDK4 inhibitors.
  • Utilizing recombinant adenoviral shRNA to specifically inhibit CDK4 expression.
  • Assessing the frequency and characteristics of neural transdifferentiation.
  • Evaluating the impact of CDK4 inhibition on syngenic differentiation.
  • Investigating the reversibility of differentiation states through forced regulation of CDK4 activity.

Main Results:

  • CDK4 inhibition selectively induced neural transdifferentiation of human MSCs at high frequencies.
  • Targeted inhibition of CDK4 expression via shRNA promoted neural differentiation.
  • Inhibition of CDK4 activity attenuated the syngenic differentiation capacity of MSCs.
  • Modulation of CDK4 activity demonstrated reciprocal control over neural differentiation and dedifferentiation.

Conclusions:

  • CDK4 signaling acts as a critical molecular switch regulating the balance between syngenic and neural transdifferentiation in human MSCs.
  • Novel molecular evidence supports the role of CDK4 in directing MSC fate towards neural lineages.
  • These findings offer new insights into the control of stem cell differentiation for potential therapeutic applications.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...